Inflammatory Activation of Astrocytes Facilitates Melanoma Brain Tropism Via the CXCL10-CXCR3 Signaling Axis
Overview
Cell Biology
Molecular Biology
Authors
Affiliations
Melanoma is the deadliest skin cancer due to its high rate of metastasis, frequently to the brain. Brain metastases are incurable; therefore, understanding melanoma brain metastasis is of great clinical importance. We used a mouse model of spontaneous melanoma brain metastasis to study the interactions of melanomas with the brain microenvironment. We find that CXCL10 is upregulated in metastasis-associated astrocytes in mice and humans and is functionally important for the chemoattraction of melanoma cells. Moreover, CXCR3, the receptor for CXCL10, is upregulated in brain-tropic melanoma cells. Targeting melanoma expression of CXCR3 by nanoparticle-mediated siRNA delivery or by shRNA transduction inhibits melanoma cell migration and attenuates brain metastasis in vivo. These findings suggest that the instigation of pro-inflammatory signaling in astrocytes is hijacked by brain-metastasizing tumor cells to promote their metastatic capacity and that the CXCL10-CXCR3 axis may be a potential therapeutic target for the prevention of melanoma brain metastasis.
Molecular Underpinnings of Brain Metastases.
Jacome M, Wu Q, Chen J, Mohamed Z, Mokhtari S, Pina Y Int J Mol Sci. 2025; 26(5).
PMID: 40076927 PMC: 11900073. DOI: 10.3390/ijms26052307.
Breaking boundaries: role of the brain barriers in metastatic process.
Izadi N, Solar P, Hasanova K, Zamani A, Akbar M, Mrazova K Fluids Barriers CNS. 2025; 22(1):3.
PMID: 39780275 PMC: 11708195. DOI: 10.1186/s12987-025-00618-z.
Regulation of metastatic organotropism.
Dunbar K, Efe G, Cunningham K, Esquea E, Navaridas R, Rustgi A Trends Cancer. 2024; 11(3):216-231.
PMID: 39732596 PMC: 11903188. DOI: 10.1016/j.trecan.2024.11.012.
Wang X, Huang W, Sun H, Wang H, Wang D, Wang Y Front Pharmacol. 2024; 15:1503925.
PMID: 39726790 PMC: 11669516. DOI: 10.3389/fphar.2024.1503925.
Abdala-Saleh N, Lugassy J, Shivakumar-Kalvhati A, Turky A, Abu Ras S, Razon H Front Immunol. 2024; 15:1452212.
PMID: 39474427 PMC: 11519525. DOI: 10.3389/fimmu.2024.1452212.